243 related articles for article (PubMed ID: 15758726)
21. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
King CR; Presti JC; Brooks JD; Gill H; Spiotto MT
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1472-7. PubMed ID: 17935902
[TBL] [Abstract][Full Text] [Related]
22. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
23. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Carini M; Masieri L; Minervini A; Lapini A; Serni S
Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
[TBL] [Abstract][Full Text] [Related]
24. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy.
Pierorazio PM; Spencer BA; McCann TR; McKiernan JM; Benson MC
Urology; 2007 Oct; 70(4):717-22. PubMed ID: 17991543
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
26. Sequential treatment for recurrent localized prostate cancer.
Van Der Poel HG; Moonen L; Horenblas S
J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
[TBL] [Abstract][Full Text] [Related]
27. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer.
Leibovici D; Kamat AM; Pettaway CA; Pagliaro L; Rosser CJ; Logothetis C; Pisters LL
J Urol; 2005 Dec; 174(6):2186-90. PubMed ID: 16280761
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
[TBL] [Abstract][Full Text] [Related]
29. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
30. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.
Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
Eur Urol; 2007 Jan; 51(1):121-8; discussion 128-9. PubMed ID: 16797831
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes.
Ray ME; Mehra R; Sandler HM; Daignault S; Shah RB
J Urol; 2006 Oct; 176(4 Pt 1):1409-14; discussion 1414. PubMed ID: 16952645
[TBL] [Abstract][Full Text] [Related]
32. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
[TBL] [Abstract][Full Text] [Related]
33. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Secin FP; Bianco FJ; Vickers AJ; Reuter V; Wheeler T; Fearn PA; Eastham JA; Scardino PT
Cancer; 2006 Jun; 106(11):2369-75. PubMed ID: 16649221
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
Carver BS; Bianco FJ; Scardino PT; Eastham JA
J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890
[TBL] [Abstract][Full Text] [Related]
35. Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer.
Lerner SE; Blute ML; Zincke H
J Urol; 1995 Sep; 154(3):1103-9. PubMed ID: 7543608
[TBL] [Abstract][Full Text] [Related]
36. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
37. Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques.
Krambeck AE; DiMarco DS; Rangel LJ; Bergstralh EJ; Myers RP; Blute ML; Gettman MT
BJU Int; 2009 Feb; 103(4):448-53. PubMed ID: 18778350
[TBL] [Abstract][Full Text] [Related]
38. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
Graefen M; Walz J; Chun KH; Schlomm T; Haese A; Huland H
Eur Urol; 2005 Jun; 47(6):756-60. PubMed ID: 15925069
[TBL] [Abstract][Full Text] [Related]
39. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
[TBL] [Abstract][Full Text] [Related]
40. Urinary continence after salvage radiation therapy following radical prostatectomy, assessed by a self-administered questionnaire: a prospective study.
Fontaine E; Ben Mouelli S; Thomas L; Otmezguine Y; Beurton D
BJU Int; 2004 Sep; 94(4):521-3. PubMed ID: 15329104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
